miR-30a inhibits endothelin A receptor and chemoresistance in ovarian carcinoma

Drug resistance remains the major clinical barrier to successful treatment in epithelial ovarian carcinoma (EOC) patients, and the evidence of microRNA involvement in drug resistance has been recently emerging. Endothelin-1 (ET-1)/ET(A) receptor (ET(A)R) axis is aberrantly activated in chemoresistan...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Oncotarget
Egile Nagusiak: Sestito, Rosanna, Cianfrocca, Roberta, Rosanò, Laura, Tocci, Piera, Semprucci, Elisa, Di Castro, Valeriana, Caprara, Valentina, Ferrandina, Gabriella, Sacconi, Andrea, Blandino, Giovanni, Bagnato, Anna
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Impact Journals LLC 2015
Gaiak:
Research Paper
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4826186/
https://ncbi.nlm.nih.gov/pubmed/26675258
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.6546
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak